August 4th, 2011
Yale Receives $2.5 Million from Medtronic for Independent Evaluation of rhBMP-2
Larry Husten, PHD
Responding to intense criticism from the government, the press, and the academic community, Medtronic announced that it was giving $2.5 million to Yale researchers to oversee independent reviews of the safety and effectiveness of rhBMP-2 (Infuse). Criticism of the spinal growth product was the sole topic of the June issue of the Spine Journal. Yale’s […]
NEJM Journal Watch — Recent Cardiology Articles- In-Hospital Cardiac Arrest: Terminating Resuscitation
- Bioprosthetic or Mechanical Surgical Aortic Valve Replacement?
- Stroke Risk in Patients with Atrial Fibrillation and Concomitant Cancer
- Can a Factor XI Inhibitor Provide the Anticoagulation Effectiveness of DOACs for AF While Improving Safety?
- MEK Inhibition in Children with RASopathy-Associated Hypertrophic Cardiomyopathy